Hypertension. 1998;31:1047-1060
(Hypertension. 1998;31:1047-1060.)
© 1998 American Heart Association, Inc.
Review of Alterations in Endothelial Nitric Oxide Production in Diabetes
Protective Role of Arginine on Endothelial Dysfunction
Galen M. Pieper
From the Department of Transplant Surgery, Medical College of Wisconsin,
Froedtert Memorial Hospital (Milwaukee).
Correspondence to Dr Galen M. Pieper, Department of Transplant Surgery, Medical College of Wisconsin, Froedtert Memorial Hospital, 9200 W Wisconsin Ave, Milwaukee, WI 53226. E-mail gmpieper@pot.its.mcw.edu
 |
Introduction
|
|---|
Nitric
oxide release from the endothelium plays an important
role in regulation of vascular tone,1 inhibition
of both platelet and leukocyte aggregation and
adhesion,1 2 and inhibition of cell
proliferation.3 These properties suggest that the
level of NO production by the endothelium may
play a pivotal role in the regulation of vascular disease.
Analysis using mass spectrometry has revealed that NO is
produced by NOS from the terminal guanidino nitrogen of the precursor
amino acid L-arginine.4 Thus,
utilization of L-arginine and conversion to NO may
establish a regulatory site in the development of
endothelial dysfunction.
Endothelial dysfunction is characterized by defective
endothelium-dependent relaxation, and some reviews
regarding endothelial dysfunction in diabetes have been
published.5 6 7 8 These reviews have focused on
factors that might contribute to defective relaxation, some of which
will not be addressed in detail in this review. The purpose of the
present review is to summarize evidence that specifically supports
either decreased NO production by diabetic vascular
endothelium and/or impaired NO-mediated
endothelium-dependent relaxation. Second, this review
provides reasonable alternatives to explain some of the controversies
in this research area. Third, since there is growing evidence that
arginine appears to have some benefits for diabetes-associated
abnormalities, this review summarizes the current state of knowledge of
effects of acute and chronic administration of L-arginine
on diabetes-induced endothelial dysfunction and
discusses potential NO-dependent and -independent mechanisms whereby
therapeutic intervention with L-arginine might benefit the
diabetic endothelium.
 |
Impaired Endothelium-Dependent Relaxation
|
|---|
Experimental Diabetes Mellitus
Decreases in endothelium-dependent relaxation are
a common feature in both conduit9 10 11 12 13 14 15 16 17 18 19 20 and
resistance21 22 23 24 25 26 27 28 29 30 . . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
T. Kobayashi, K. Taguchi, S. Nemoto, T. Nogami, T. Matsumoto, and K. Kamata
Activation of the PDK-1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2009;
297(5):
H1767 - H1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, N. Nakayama, K. Ishida, T. Kobayashi, and K. Kamata
Eicosapentaenoic Acid Improves Imbalance between Vasodilator and Vasoconstrictor Actions of Endothelium-Derived Factors in Mesenteric Arteries from Rats at Chronic Stage of Type 2 Diabetes
J. Pharmacol. Exp. Ther.,
April 1, 2009;
329(1):
324 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata
Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H1165 - H1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Brands and H. Labazi
Role of Glomerular Filtration Rate in Controlling Blood Pressure Early in Diabetes
Hypertension,
August 1, 2008;
52(2):
188 - 194.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Harris, M. M. Elgebaly, W. Li, K. Sachidanandam, and A. Ergul
Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2008;
294(4):
R1213 - R1219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ren, J. Duan, D. P. Thomas, X. Yang, N. Sreejayan, J. R. Sowers, A. Leri, J. Kajstura, F. Gao, and P. Anversa
IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2008;
294(3):
R793 - R802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wu, J. K. Collins, P. Perkins-Veazie, M. Siddiq, K. D. Dolan, K. A. Kelly, C. L. Heaps, and C. J. Meininger
Dietary Supplementation with Watermelon Pomace Juice Enhances Arginine Availability and Ameliorates the Metabolic Syndrome in Zucker Diabetic Fatty Rats
J. Nutr.,
December 1, 2007;
137(12):
2680 - 2685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, M. Kakami, E. Noguchi, T. Kobayashi, and K. Kamata
Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1480 - H1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simionescu
Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease
Arterioscler Thromb Vasc Biol,
February 1, 2007;
27(2):
266 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Elrod, M. R. Duranski, W. Langston, J. J.M. Greer, L. Tao, T. R. Dugas, C. G. Kevil, H. C. Champion, and D. J. Lefer
eNOS Gene Therapy Exacerbates Hepatic Ischemia-Reperfusion Injury in Diabetes: A Role for eNOS Uncoupling
Circ. Res.,
July 7, 2006;
99(1):
78 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Komers, W. E. Schutzer, J. F. Reed, J. N. Lindsley, T. T. Oyama, D. C. Buck, S. L. Mader, and S. Anderson
Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney
Diabetes,
June 1, 2006;
55(6):
1651 - 1659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ito, Y. P. R. Jarajapu, D. L. Guberski, M. B. Grant, and H. J. Knot
Myogenic Tone and Reactivity of Rat Ophthalmic Artery in Acute Exposure to High Glucose and in a Type II Diabetic Model
Invest. Ophthalmol. Vis. Sci.,
February 1, 2006;
47(2):
683 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Bubolz, H. Li, Q. Wu, and Y. Liu
Enhanced oxidative stress impairs cAMP-mediated dilation by reducing Kv channel function in small coronary arteries of diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1873 - H1880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, T. Kobayashi, K. Wakabayashi, and K. Kamata
Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1933 - H1940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H2234 - H2243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Weekers, B. Bouhanick, S. Hadjadj, Y. Gallois, R. Roussel, F. Pean, A. Ankotche, G. Chatellier, F. Alhenc-Gelas, P. J. Lefebvre, et al.
Modulation of the Renal Response to ACE Inhibition by ACE Insertion/Deletion Polymorphism During Hyperglycemia in Normotensive, Normoalbuminuric Type 1 Diabetic Patients
Diabetes,
October 1, 2005;
54(10):
2961 - 2967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Fu, T. E. Haynes, R. Kohli, J. Hu, W. Shi, T. E. Spencer, R. J. Carroll, C. J. Meininger, and G. Wu
Dietary L-Arginine Supplementation Reduces Fat Mass in Zucker Diabetic Fatty Rats
J. Nutr.,
April 1, 2005;
135(4):
714 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, K. Taguchi, T. Yasuhiro, T. Matsumoto, and K. Kamata
Impairment of PI3-K/Akt Pathway Underlies Attenuated Endothelial Function in Aorta of Type 2 Diabetic Mouse Model
Hypertension,
December 1, 2004;
44(6):
956 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1064 - H1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Setty, W. Sun, R. Martinez, H. F. Downey, and J. D. Tune
{alpha}-Adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus
J Appl Physiol,
July 1, 2004;
97(1):
431 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata
Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats
Am J Physiol Heart Circ Physiol,
July 1, 2004;
287(1):
H135 - H148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sigaudo-Roussel, C. Demiot, B. Fromy, A. Koitka, G. Leftheriotis, P. Abraham, and J. L. Saumet
Early Endothelial Dysfunction Severely Impairs Skin Blood Flow Response to Local Pressure Application in Streptozotocin-Induced Diabetic Mice
Diabetes,
June 1, 2004;
53(6):
1564 - 1569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Komers, R. Simkova, L. Kazdova, J. Ruzickova, and T. Pelikanova
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes
Journal of Renin-Angiotensin-Aldosterone System,
March 1, 2004;
5(1):
33 - 38.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Koitka, P. Abraham, B. Bouhanick, D. Sigaudo-Roussel, C. Demiot, and J. L. Saumet
Impaired Pressure-Induced Vasodilation at the Foot in Young Adults With Type 1 Diabetes
Diabetes,
March 1, 2004;
53(3):
721 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kohli, C. J. Meininger, T. E. Haynes, W. Yan, J. T. Self, and G. Wu
Dietary L-Arginine Supplementation Enhances Endothelial Nitric Oxide Synthesis in Streptozotocin-Induced Diabetic Rats
J. Nutr.,
March 1, 2004;
134(3):
600 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Gunnett, D. D. Heistad, and F. M. Faraci
Gene-Targeted Mice Reveal a Critical Role for Inducible Nitric Oxide Synthase in Vascular Dysfunction During Diabetes
Stroke,
December 1, 2003;
34(12):
2970 - 2974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Bagi, A. Koller, and G. Kaley
Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol,
October 1, 2003;
285(4):
H1404 - H1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Morris, S. M. Morris Jr., W. Hagar, J. van Warmerdam, S. Claster, D. Kepka-Lenhart, L. Machado, F. A. Kuypers, and E. P. Vichinsky
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Am. J. Respir. Crit. Care Med.,
July 1, 2003;
168(1):
63 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, T. Kobayashi, and K. Kamata
Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H283 - H291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Komers and S. Anderson
Paradoxes of nitric oxide in the diabetic kidney
Am J Physiol Renal Physiol,
June 1, 2003;
284(6):
F1121 - F1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Flores, S. Rojas, C. Aguayo, J. Parodi, G. Mann, J. D. Pearson, P. Casanello, and L. Sobrevia
Rapid Stimulation of L-Arginine Transport by D-Glucose Involves p42/44mapk and Nitric Oxide in Human Umbilical Vein Endothelium
Circ. Res.,
January 10, 2003;
92(1):
64 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Fernandez-Real, G. Penarroja, C. Richart, A. Castro, J. Vendrell, M. Broch, A. Lopez-Bermejo, and W. Ricart
G Protein {beta}3 Gene Variant, Vascular Function, and Insulin Sensitivity in Type 2 Diabetes
Hypertension,
January 1, 2003;
41(1):
124 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Mullan, I. S. Young, H. Fee, and D. R. McCance
Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
Hypertension,
December 1, 2002;
40(6):
804 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi and K. Kamata
Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats
Am J Physiol Heart Circ Physiol,
November 1, 2002;
283(5):
H1761 - H1768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Yorek, L. J. Coppey, J. S. Gellett, E. P. Davidson, X. Bing, D. D. Lund, and J. S. Dillon
Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function
Am J Physiol Endocrinol Metab,
November 1, 2002;
283(5):
E1067 - E1075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Huynh and J. A. Tayek
Oral Arginine Reduces Systemic Blood Pressure in Type 2 Diabetes: Its Potential Role in Nitric Oxide Generation
J. Am. Coll. Nutr.,
October 1, 2002;
21(5):
422 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chandra, E. B. Jackson, K. V. Ramana, R. Kelley, S. K. Srivastava, and A. Bhatnagar
Nitric Oxide Prevents Aldose Reductase Activation and Sorbitol Accumulation During Diabetes
Diabetes,
October 1, 2002;
51(10):
3095 - 3101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thomsen, I. Rubin, and M. Lauritzen
NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy
J. Physiol.,
September 15, 2002;
543(3):
977 - 993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tousoulis, C. Antoniades, C. Tentolouris, G. Goumas, C. Stefanadis, and P. Toutouzas
L-Arginine in cardiovascular disease: dream or reality?
Vascular Medicine,
August 1, 2002;
7(3):
203 - 211.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Gunnett, D. D. Heistad, and F. M. Faraci
Interleukin-10 Protects Nitric Oxide-Dependent Relaxation During Diabetes: Role of Superoxide
Diabetes,
June 1, 2002;
51(6):
1931 - 1937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fromy, P. Abraham, C. Bouvet, B. Bouhanick, P. Fressinaud, and J. L. Saumet
Early Decrease of Skin Blood Flow in Response to Locally Applied Pressure in Diabetic Subjects
Diabetes,
April 1, 2002;
51(4):
1214 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Parodi, C. Flores, C. Aguayo, M. I. Rudolph, P. Casanello, and L. Sobrevia
Inhibition of Nitrobenzylthioinosine-Sensitive Adenosine Transport by Elevated D-Glucose Involves Activation of P2Y2 Purinoceptors in Human Umbilical Vein Endothelial Cells
Circ. Res.,
March 22, 2002;
90(5):
570 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Misurski, R. L. Hopfner, and V. Gopalakrishnan
Attenuated Agonist Evoked Vasoconstrictor Responses in the Perfused Mesenteric Vascular Bed of Streptozotocin Diabetic Rats
Experimental Biology and Medicine,
November 1, 2001;
226(10):
940 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rask-Madsen, N. Ihlemann, T. Krarup, E. Christiansen, L. Kober, C. Nervil Kistorp, and C. Torp-Pedersen
Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease
Diabetes,
November 1, 2001;
50(11):
2611 - 2618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Davidge
Prostaglandin H Synthase and Vascular Function
Circ. Res.,
October 12, 2001;
89(8):
650 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Zharikov, A. A. Sigova, S. Chen, M. R. Bubb, and E. R. Block
Cytoskeletal regulation of the L-arginine/NO pathway in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol,
March 1, 2001;
280(3):
L465 - L473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kimura, M. Oike, T. Koyama, and Y. Ito
Impairment of endothelial nitric oxide production by acute glucose overload
Am J Physiol Endocrinol Metab,
January 1, 2001;
280(1):
E171 - E178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. SCALIA, K. M. COYLE, B. J. LEVINE, G. BOOTH, and A. M. LEFER
C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction
FASEB J,
November 1, 2000;
14(14):
2357 - 2364.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Wu and C. J. Meininger
Arginine Nutrition and Cardiovascular Function
J. Nutr.,
November 1, 2000;
130(11):
2626 - 2629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Fitzgerald and M. W. Brands
Nitric oxide may be required to prevent hypertension at the onset of diabetes
Am J Physiol Endocrinol Metab,
October 1, 2000;
279(4):
E762 - E768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Young, Y. Ikeda, R. Scalia, and A. M. Lefer
C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion
Am J Physiol Heart Circ Physiol,
October 1, 2000;
279(4):
H1453 - H1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Komers, J. N. Lindsley, T. T. Oyama, K. M. Allison, and S. Anderson
Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes
Am J Physiol Renal Physiol,
September 1, 2000;
279(3):
F573 - F583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. PIATTI, L. D. MONTI, I. ZAVARONI, G. VALSECCHI, C. VAN PHAN, S. COSTA, M. CONTI, E. P. SANDOLI, B. SOLERTE, G. POZZA, et al.
Alterations in Nitric Oxide/Cyclic-GMP Pathway in Nondiabetic Siblings of Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
July 1, 2000;
85(7):
2416 - 2420.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. G. Seo, T. Nishinaka, and C. Yabe-Nishimura
Nitric Oxide Up-Regulates Aldose Reductase Expression in Rat Vascular Smooth Muscle Cells: A Potential Role for Aldose Reductase in Vascular Remodeling
Mol. Pharmacol.,
April 1, 2000;
57(4):
709 - 717.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Komers, T. T. Oyama, J. G. Chapman, K. M. Allison, and S. Anderson
Effects of Systemic Inhibition of Neuronal Nitric Oxide Synthase in Diabetic Rats
Hypertension,
February 1, 2000;
35(2):
655 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Claxton, M. W. Brands, S. M. Fitzgerald, and J. A. Cameron
Inhibition of Nitric Oxide Synthesis Potentiates Hypertension During Chronic Glucose Infusion in Rats
Hypertension,
January 1, 2000;
35(1):
451 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Lim, A. E. Caballero, S. Arora, P. Smakowski, E. M. Bashoff, F. M. Brown, F. W. Logerfo, E. S. Horton, and A. Veves
The Effect of Hormonal Replacement Therapy on the Vascular Reactivity and Endothelial Function of Healthy Individuals and Individuals with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
November 1, 1999;
84(11):
4159 - 4164.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Joyeux, P. Faure, D. Godin-Ribuot, S. Halimi, A. Patel, D. M Yellon, P. Demenge, and C. Ribuot
Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarction
Cardiovasc Res,
September 1, 1999;
43(4):
939 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kojda and D. Harrison
Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
Cardiovasc Res,
August 15, 1999;
43(3):
652 - 671.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. MILLER
Impact of Hyperglycemia on the Renin Angiotensin System in Early Human Type 1 Diabetes Mellitus
J. Am. Soc. Nephrol.,
August 1, 1999;
10(8):
1778 - 1785.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. A. Gupte, T. Rupawalla, K. M. Mohazzab-H., and M. S. Wolin
Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD
Am J Physiol Heart Circ Physiol,
May 1, 1999;
276(5):
H1535 - H1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Pflueger, H. Osswald, and F. G. Knox
Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide
Am J Physiol Renal Physiol,
March 1, 1999;
276(3):
F340 - F346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Fernandez-Real, B. Lainez, J. Vendrell, M. Rigla, A. Castro, G. Penarroja, M. Broch, A. Perez, C. Richart, P. Engel, et al.
Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus
Am J Physiol Endocrinol Metab,
April 1, 2002;
282(4):
E952 - E959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Fitzgerald and M. W. Brands
Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2002;
282(4):
R1070 - R1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Parodi, C. Flores, C. Aguayo, M. I. Rudolph, P. Casanello, and L. Sobrevia
Inhibition of Nitrobenzylthioinosine-Sensitive Adenosine Transport by Elevated D-Glucose Involves Activation of P2Y2 Purinoceptors in Human Umbilical Vein Endothelial Cells
Circ. Res.,
March 22, 2002;
90(5):
570 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai, and K. M. Channon
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase
Circulation,
April 9, 2002;
105(14):
1656 - 1662.
[Abstract]
[Full Text]
[PDF]
|
 |
|